nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—CYP3A4—bone cancer	0.559	1	CbGaD
Zonisamide—AOX1—Methotrexate—bone cancer	0.0185	0.943	CbGbCtD
Zonisamide—CA2—periosteum—bone cancer	0.00238	0.0673	CbGeAlD
Zonisamide—SCN2B—spinal cord—bone cancer	0.00203	0.0574	CbGeAlD
Zonisamide—CA10—spinal cord—bone cancer	0.00176	0.0498	CbGeAlD
Zonisamide—SCN3B—tendon—bone cancer	0.00175	0.0497	CbGeAlD
Zonisamide—SCN3B—spinal cord—bone cancer	0.00169	0.0479	CbGeAlD
Zonisamide—CA13—tendon—bone cancer	0.00153	0.0433	CbGeAlD
Zonisamide—SCN4B—tendon—bone cancer	0.00149	0.0422	CbGeAlD
Zonisamide—SCN4B—spinal cord—bone cancer	0.00144	0.0407	CbGeAlD
Zonisamide—CA11—tendon—bone cancer	0.00128	0.0363	CbGeAlD
Zonisamide—CA11—bone marrow—bone cancer	0.00124	0.0352	CbGeAlD
Zonisamide—CA11—spinal cord—bone cancer	0.00124	0.0351	CbGeAlD
Zonisamide—CA3—connective tissue—bone cancer	0.00114	0.0323	CbGeAlD
Zonisamide—CYP3A4—Doxorubicin—bone cancer	0.00113	0.0574	CbGbCtD
Zonisamide—SCN11A—spinal cord—bone cancer	0.00101	0.0286	CbGeAlD
Zonisamide—CA12—connective tissue—bone cancer	0.000807	0.0228	CbGeAlD
Zonisamide—CA3—tendon—bone cancer	0.000784	0.0222	CbGeAlD
Zonisamide—CA3—bone marrow—bone cancer	0.000759	0.0215	CbGeAlD
Zonisamide—CA9—tendon—bone cancer	0.00075	0.0212	CbGeAlD
Zonisamide—CA14—tendon—bone cancer	0.000712	0.0201	CbGeAlD
Zonisamide—SCN9A—tendon—bone cancer	0.000697	0.0197	CbGeAlD
Zonisamide—CA14—spinal cord—bone cancer	0.000686	0.0194	CbGeAlD
Zonisamide—SCN9A—spinal cord—bone cancer	0.000672	0.019	CbGeAlD
Zonisamide—SCN4A—tendon—bone cancer	0.000622	0.0176	CbGeAlD
Zonisamide—SCN1A—spinal cord—bone cancer	0.000578	0.0164	CbGeAlD
Zonisamide—SCN2A—spinal cord—bone cancer	0.000531	0.015	CbGeAlD
Zonisamide—MAOB—connective tissue—bone cancer	0.000519	0.0147	CbGeAlD
Zonisamide—CA5B—tendon—bone cancer	0.000498	0.0141	CbGeAlD
Zonisamide—SCN3A—tendon—bone cancer	0.000484	0.0137	CbGeAlD
Zonisamide—SCN3A—bone marrow—bone cancer	0.000469	0.0133	CbGeAlD
Zonisamide—SCN3A—spinal cord—bone cancer	0.000467	0.0132	CbGeAlD
Zonisamide—AOX1—tendon—bone cancer	0.000463	0.0131	CbGeAlD
Zonisamide—MAOA—connective tissue—bone cancer	0.000443	0.0125	CbGeAlD
Zonisamide—CA1—bone marrow—bone cancer	0.000426	0.0121	CbGeAlD
Zonisamide—CA1—spinal cord—bone cancer	0.000424	0.012	CbGeAlD
Zonisamide—Eosinophilia—Doxorubicin—bone cancer	0.000417	0.00142	CcSEcCtD
Zonisamide—Sweating—Methotrexate—bone cancer	0.000416	0.00142	CcSEcCtD
Zonisamide—Feeling abnormal—Cisplatin—bone cancer	0.000415	0.00142	CcSEcCtD
Zonisamide—CA2—connective tissue—bone cancer	0.000415	0.0117	CbGeAlD
Zonisamide—Weight increased—Epirubicin—bone cancer	0.000414	0.00141	CcSEcCtD
Zonisamide—Haematuria—Methotrexate—bone cancer	0.000413	0.00141	CcSEcCtD
Zonisamide—Pancreatitis—Doxorubicin—bone cancer	0.000413	0.00141	CcSEcCtD
Zonisamide—Weight decreased—Epirubicin—bone cancer	0.000412	0.00141	CcSEcCtD
Zonisamide—Hepatobiliary disease—Methotrexate—bone cancer	0.00041	0.0014	CcSEcCtD
Zonisamide—Pneumonia—Epirubicin—bone cancer	0.000408	0.00139	CcSEcCtD
Zonisamide—Agranulocytosis—Methotrexate—bone cancer	0.000404	0.00138	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000402	0.00137	CcSEcCtD
Zonisamide—Pancytopenia—Doxorubicin—bone cancer	0.0004	0.00136	CcSEcCtD
Zonisamide—Renal failure—Epirubicin—bone cancer	0.000399	0.00136	CcSEcCtD
Zonisamide—Body temperature increased—Cisplatin—bone cancer	0.000398	0.00136	CcSEcCtD
Zonisamide—Neuropathy peripheral—Epirubicin—bone cancer	0.000398	0.00136	CcSEcCtD
Zonisamide—Stomatitis—Epirubicin—bone cancer	0.000395	0.00135	CcSEcCtD
Zonisamide—Conjunctivitis—Epirubicin—bone cancer	0.000394	0.00135	CcSEcCtD
Zonisamide—Urinary tract infection—Epirubicin—bone cancer	0.000394	0.00135	CcSEcCtD
Zonisamide—Dysuria—Doxorubicin—bone cancer	0.000394	0.00134	CcSEcCtD
Zonisamide—Sweating—Epirubicin—bone cancer	0.000389	0.00133	CcSEcCtD
Zonisamide—Pollakiuria—Doxorubicin—bone cancer	0.000389	0.00133	CcSEcCtD
Zonisamide—Haematuria—Epirubicin—bone cancer	0.000387	0.00132	CcSEcCtD
Zonisamide—Pharyngitis—Methotrexate—bone cancer	0.000386	0.00132	CcSEcCtD
Zonisamide—Urinary tract disorder—Methotrexate—bone cancer	0.000384	0.00131	CcSEcCtD
Zonisamide—Hepatobiliary disease—Epirubicin—bone cancer	0.000384	0.00131	CcSEcCtD
Zonisamide—Weight increased—Doxorubicin—bone cancer	0.000383	0.00131	CcSEcCtD
Zonisamide—Urethral disorder—Methotrexate—bone cancer	0.000381	0.0013	CcSEcCtD
Zonisamide—Weight decreased—Doxorubicin—bone cancer	0.000381	0.0013	CcSEcCtD
Zonisamide—Agranulocytosis—Epirubicin—bone cancer	0.000379	0.00129	CcSEcCtD
Zonisamide—Pneumonia—Doxorubicin—bone cancer	0.000377	0.00129	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000372	0.00127	CcSEcCtD
Zonisamide—Hypersensitivity—Cisplatin—bone cancer	0.000371	0.00127	CcSEcCtD
Zonisamide—Bradycardia—Epirubicin—bone cancer	0.000371	0.00127	CcSEcCtD
Zonisamide—Renal failure—Doxorubicin—bone cancer	0.000369	0.00126	CcSEcCtD
Zonisamide—Erythema multiforme—Methotrexate—bone cancer	0.000368	0.00126	CcSEcCtD
Zonisamide—Neuropathy peripheral—Doxorubicin—bone cancer	0.000368	0.00126	CcSEcCtD
Zonisamide—Stomatitis—Doxorubicin—bone cancer	0.000366	0.00125	CcSEcCtD
Zonisamide—Rhinitis—Epirubicin—bone cancer	0.000365	0.00125	CcSEcCtD
Zonisamide—Conjunctivitis—Doxorubicin—bone cancer	0.000365	0.00125	CcSEcCtD
Zonisamide—Urinary tract infection—Doxorubicin—bone cancer	0.000365	0.00125	CcSEcCtD
Zonisamide—Eye disorder—Methotrexate—bone cancer	0.000364	0.00124	CcSEcCtD
Zonisamide—Tinnitus—Methotrexate—bone cancer	0.000363	0.00124	CcSEcCtD
Zonisamide—Asthenia—Cisplatin—bone cancer	0.000361	0.00123	CcSEcCtD
Zonisamide—Pharyngitis—Epirubicin—bone cancer	0.000361	0.00123	CcSEcCtD
Zonisamide—Sweating—Doxorubicin—bone cancer	0.00036	0.00123	CcSEcCtD
Zonisamide—Urinary tract disorder—Epirubicin—bone cancer	0.00036	0.00123	CcSEcCtD
Zonisamide—Oedema peripheral—Epirubicin—bone cancer	0.000359	0.00122	CcSEcCtD
Zonisamide—Haematuria—Doxorubicin—bone cancer	0.000358	0.00122	CcSEcCtD
Zonisamide—Connective tissue disorder—Epirubicin—bone cancer	0.000358	0.00122	CcSEcCtD
Zonisamide—Urethral disorder—Epirubicin—bone cancer	0.000357	0.00122	CcSEcCtD
Zonisamide—MAOB—tendon—bone cancer	0.000357	0.0101	CbGeAlD
Zonisamide—Hepatobiliary disease—Doxorubicin—bone cancer	0.000355	0.00121	CcSEcCtD
Zonisamide—Immune system disorder—Methotrexate—bone cancer	0.000351	0.0012	CcSEcCtD
Zonisamide—Mediastinal disorder—Methotrexate—bone cancer	0.000351	0.0012	CcSEcCtD
Zonisamide—Agranulocytosis—Doxorubicin—bone cancer	0.00035	0.0012	CcSEcCtD
Zonisamide—Diarrhoea—Cisplatin—bone cancer	0.000345	0.00118	CcSEcCtD
Zonisamide—Erythema multiforme—Epirubicin—bone cancer	0.000344	0.00118	CcSEcCtD
Zonisamide—MAOB—spinal cord—bone cancer	0.000344	0.00974	CbGeAlD
Zonisamide—Alopecia—Methotrexate—bone cancer	0.000344	0.00117	CcSEcCtD
Zonisamide—CA4—tendon—bone cancer	0.000344	0.00972	CbGeAlD
Zonisamide—Bradycardia—Doxorubicin—bone cancer	0.000343	0.00117	CcSEcCtD
Zonisamide—Mental disorder—Methotrexate—bone cancer	0.000341	0.00116	CcSEcCtD
Zonisamide—Eye disorder—Epirubicin—bone cancer	0.00034	0.00116	CcSEcCtD
Zonisamide—Tinnitus—Epirubicin—bone cancer	0.000339	0.00116	CcSEcCtD
Zonisamide—Malnutrition—Methotrexate—bone cancer	0.000339	0.00116	CcSEcCtD
Zonisamide—Rhinitis—Doxorubicin—bone cancer	0.000338	0.00115	CcSEcCtD
Zonisamide—Pharyngitis—Doxorubicin—bone cancer	0.000334	0.00114	CcSEcCtD
Zonisamide—CA4—bone marrow—bone cancer	0.000333	0.00942	CbGeAlD
Zonisamide—Urinary tract disorder—Doxorubicin—bone cancer	0.000333	0.00114	CcSEcCtD
Zonisamide—Oedema peripheral—Doxorubicin—bone cancer	0.000332	0.00113	CcSEcCtD
Zonisamide—Dysgeusia—Methotrexate—bone cancer	0.000332	0.00113	CcSEcCtD
Zonisamide—CA4—spinal cord—bone cancer	0.000331	0.00938	CbGeAlD
Zonisamide—Connective tissue disorder—Doxorubicin—bone cancer	0.000331	0.00113	CcSEcCtD
Zonisamide—Urethral disorder—Doxorubicin—bone cancer	0.00033	0.00113	CcSEcCtD
Zonisamide—Immune system disorder—Epirubicin—bone cancer	0.000329	0.00112	CcSEcCtD
Zonisamide—Mediastinal disorder—Epirubicin—bone cancer	0.000328	0.00112	CcSEcCtD
Zonisamide—Alopecia—Epirubicin—bone cancer	0.000322	0.0011	CcSEcCtD
Zonisamide—Vomiting—Cisplatin—bone cancer	0.00032	0.00109	CcSEcCtD
Zonisamide—Mental disorder—Epirubicin—bone cancer	0.000319	0.00109	CcSEcCtD
Zonisamide—Erythema multiforme—Doxorubicin—bone cancer	0.000319	0.00109	CcSEcCtD
Zonisamide—Rash—Cisplatin—bone cancer	0.000318	0.00108	CcSEcCtD
Zonisamide—Dermatitis—Cisplatin—bone cancer	0.000317	0.00108	CcSEcCtD
Zonisamide—Malnutrition—Epirubicin—bone cancer	0.000317	0.00108	CcSEcCtD
Zonisamide—Eye disorder—Doxorubicin—bone cancer	0.000315	0.00108	CcSEcCtD
Zonisamide—Ill-defined disorder—Methotrexate—bone cancer	0.000314	0.00107	CcSEcCtD
Zonisamide—Tinnitus—Doxorubicin—bone cancer	0.000314	0.00107	CcSEcCtD
Zonisamide—Anaemia—Methotrexate—bone cancer	0.000313	0.00107	CcSEcCtD
Zonisamide—Flatulence—Epirubicin—bone cancer	0.000312	0.00107	CcSEcCtD
Zonisamide—Tension—Epirubicin—bone cancer	0.000311	0.00106	CcSEcCtD
Zonisamide—Dysgeusia—Epirubicin—bone cancer	0.00031	0.00106	CcSEcCtD
Zonisamide—Nervousness—Epirubicin—bone cancer	0.000308	0.00105	CcSEcCtD
Zonisamide—Malaise—Methotrexate—bone cancer	0.000305	0.00104	CcSEcCtD
Zonisamide—Muscle spasms—Epirubicin—bone cancer	0.000305	0.00104	CcSEcCtD
Zonisamide—MAOA—tendon—bone cancer	0.000304	0.00861	CbGeAlD
Zonisamide—Immune system disorder—Doxorubicin—bone cancer	0.000304	0.00104	CcSEcCtD
Zonisamide—Vertigo—Methotrexate—bone cancer	0.000304	0.00104	CcSEcCtD
Zonisamide—Mediastinal disorder—Doxorubicin—bone cancer	0.000304	0.00104	CcSEcCtD
Zonisamide—Leukopenia—Methotrexate—bone cancer	0.000303	0.00104	CcSEcCtD
Zonisamide—Nausea—Cisplatin—bone cancer	0.000299	0.00102	CcSEcCtD
Zonisamide—Alopecia—Doxorubicin—bone cancer	0.000298	0.00102	CcSEcCtD
Zonisamide—Cough—Methotrexate—bone cancer	0.000296	0.00101	CcSEcCtD
Zonisamide—Mental disorder—Doxorubicin—bone cancer	0.000295	0.00101	CcSEcCtD
Zonisamide—Ill-defined disorder—Epirubicin—bone cancer	0.000294	0.001	CcSEcCtD
Zonisamide—MAOA—spinal cord—bone cancer	0.000294	0.00831	CbGeAlD
Zonisamide—Convulsion—Methotrexate—bone cancer	0.000293	0.001	CcSEcCtD
Zonisamide—Malnutrition—Doxorubicin—bone cancer	0.000293	0.001	CcSEcCtD
Zonisamide—Anaemia—Epirubicin—bone cancer	0.000293	0.001	CcSEcCtD
Zonisamide—Agitation—Epirubicin—bone cancer	0.000291	0.000995	CcSEcCtD
Zonisamide—Flatulence—Doxorubicin—bone cancer	0.000289	0.000987	CcSEcCtD
Zonisamide—Arthralgia—Methotrexate—bone cancer	0.000288	0.000985	CcSEcCtD
Zonisamide—Chest pain—Methotrexate—bone cancer	0.000288	0.000985	CcSEcCtD
Zonisamide—Myalgia—Methotrexate—bone cancer	0.000288	0.000985	CcSEcCtD
Zonisamide—Tension—Doxorubicin—bone cancer	0.000288	0.000983	CcSEcCtD
Zonisamide—Dysgeusia—Doxorubicin—bone cancer	0.000287	0.000981	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000286	0.000978	CcSEcCtD
Zonisamide—Malaise—Epirubicin—bone cancer	0.000286	0.000976	CcSEcCtD
Zonisamide—CA2—tendon—bone cancer	0.000285	0.00806	CbGeAlD
Zonisamide—Discomfort—Methotrexate—bone cancer	0.000285	0.000973	CcSEcCtD
Zonisamide—Nervousness—Doxorubicin—bone cancer	0.000285	0.000973	CcSEcCtD
Zonisamide—Vertigo—Epirubicin—bone cancer	0.000285	0.000972	CcSEcCtD
Zonisamide—Syncope—Epirubicin—bone cancer	0.000284	0.000971	CcSEcCtD
Zonisamide—Leukopenia—Epirubicin—bone cancer	0.000284	0.000969	CcSEcCtD
Zonisamide—Muscle spasms—Doxorubicin—bone cancer	0.000282	0.000963	CcSEcCtD
Zonisamide—Palpitations—Epirubicin—bone cancer	0.00028	0.000956	CcSEcCtD
Zonisamide—Confusional state—Methotrexate—bone cancer	0.000279	0.000952	CcSEcCtD
Zonisamide—Loss of consciousness—Epirubicin—bone cancer	0.000279	0.000951	CcSEcCtD
Zonisamide—Cough—Epirubicin—bone cancer	0.000277	0.000944	CcSEcCtD
Zonisamide—CA2—bone marrow—bone cancer	0.000276	0.00781	CbGeAlD
Zonisamide—CA2—spinal cord—bone cancer	0.000275	0.00778	CbGeAlD
Zonisamide—Convulsion—Epirubicin—bone cancer	0.000275	0.000938	CcSEcCtD
Zonisamide—Infection—Methotrexate—bone cancer	0.000275	0.000938	CcSEcCtD
Zonisamide—Hypertension—Epirubicin—bone cancer	0.000274	0.000934	CcSEcCtD
Zonisamide—Ill-defined disorder—Doxorubicin—bone cancer	0.000272	0.000929	CcSEcCtD
Zonisamide—Nervous system disorder—Methotrexate—bone cancer	0.000271	0.000926	CcSEcCtD
Zonisamide—Anaemia—Doxorubicin—bone cancer	0.000271	0.000926	CcSEcCtD
Zonisamide—Thrombocytopenia—Methotrexate—bone cancer	0.000271	0.000924	CcSEcCtD
Zonisamide—Myalgia—Epirubicin—bone cancer	0.00027	0.000921	CcSEcCtD
Zonisamide—Arthralgia—Epirubicin—bone cancer	0.00027	0.000921	CcSEcCtD
Zonisamide—Chest pain—Epirubicin—bone cancer	0.00027	0.000921	CcSEcCtD
Zonisamide—Agitation—Doxorubicin—bone cancer	0.00027	0.00092	CcSEcCtD
Zonisamide—Anxiety—Epirubicin—bone cancer	0.000269	0.000918	CcSEcCtD
Zonisamide—Skin disorder—Methotrexate—bone cancer	0.000268	0.000917	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000268	0.000915	CcSEcCtD
Zonisamide—Hyperhidrosis—Methotrexate—bone cancer	0.000267	0.000912	CcSEcCtD
Zonisamide—Discomfort—Epirubicin—bone cancer	0.000267	0.00091	CcSEcCtD
Zonisamide—Malaise—Doxorubicin—bone cancer	0.000264	0.000903	CcSEcCtD
Zonisamide—Dry mouth—Epirubicin—bone cancer	0.000264	0.000901	CcSEcCtD
Zonisamide—Vertigo—Doxorubicin—bone cancer	0.000263	0.0009	CcSEcCtD
Zonisamide—Anorexia—Methotrexate—bone cancer	0.000263	0.0009	CcSEcCtD
Zonisamide—Syncope—Doxorubicin—bone cancer	0.000263	0.000898	CcSEcCtD
Zonisamide—Leukopenia—Doxorubicin—bone cancer	0.000263	0.000896	CcSEcCtD
Zonisamide—Confusional state—Epirubicin—bone cancer	0.000261	0.000891	CcSEcCtD
Zonisamide—Palpitations—Doxorubicin—bone cancer	0.000259	0.000885	CcSEcCtD
Zonisamide—Oedema—Epirubicin—bone cancer	0.000259	0.000883	CcSEcCtD
Zonisamide—Hypotension—Methotrexate—bone cancer	0.000258	0.000882	CcSEcCtD
Zonisamide—Loss of consciousness—Doxorubicin—bone cancer	0.000258	0.00088	CcSEcCtD
Zonisamide—Infection—Epirubicin—bone cancer	0.000257	0.000878	CcSEcCtD
Zonisamide—Cough—Doxorubicin—bone cancer	0.000256	0.000874	CcSEcCtD
Zonisamide—Shock—Epirubicin—bone cancer	0.000255	0.000869	CcSEcCtD
Zonisamide—Convulsion—Doxorubicin—bone cancer	0.000254	0.000868	CcSEcCtD
Zonisamide—Nervous system disorder—Epirubicin—bone cancer	0.000254	0.000866	CcSEcCtD
Zonisamide—Thrombocytopenia—Epirubicin—bone cancer	0.000253	0.000865	CcSEcCtD
Zonisamide—Hypertension—Doxorubicin—bone cancer	0.000253	0.000865	CcSEcCtD
Zonisamide—Tachycardia—Epirubicin—bone cancer	0.000252	0.000862	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000252	0.00086	CcSEcCtD
Zonisamide—Skin disorder—Epirubicin—bone cancer	0.000251	0.000858	CcSEcCtD
Zonisamide—Hyperhidrosis—Epirubicin—bone cancer	0.00025	0.000854	CcSEcCtD
Zonisamide—Insomnia—Methotrexate—bone cancer	0.00025	0.000854	CcSEcCtD
Zonisamide—Chest pain—Doxorubicin—bone cancer	0.00025	0.000853	CcSEcCtD
Zonisamide—Myalgia—Doxorubicin—bone cancer	0.00025	0.000853	CcSEcCtD
Zonisamide—Arthralgia—Doxorubicin—bone cancer	0.00025	0.000853	CcSEcCtD
Zonisamide—Anxiety—Doxorubicin—bone cancer	0.000249	0.00085	CcSEcCtD
Zonisamide—Paraesthesia—Methotrexate—bone cancer	0.000248	0.000848	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000248	0.000847	CcSEcCtD
Zonisamide—Discomfort—Doxorubicin—bone cancer	0.000247	0.000842	CcSEcCtD
Zonisamide—Anorexia—Epirubicin—bone cancer	0.000247	0.000842	CcSEcCtD
Zonisamide—Dyspnoea—Methotrexate—bone cancer	0.000246	0.000842	CcSEcCtD
Zonisamide—Somnolence—Methotrexate—bone cancer	0.000246	0.000839	CcSEcCtD
Zonisamide—Dry mouth—Doxorubicin—bone cancer	0.000244	0.000834	CcSEcCtD
Zonisamide—Dyspepsia—Methotrexate—bone cancer	0.000243	0.000831	CcSEcCtD
Zonisamide—Hypotension—Epirubicin—bone cancer	0.000242	0.000825	CcSEcCtD
Zonisamide—Confusional state—Doxorubicin—bone cancer	0.000241	0.000824	CcSEcCtD
Zonisamide—Decreased appetite—Methotrexate—bone cancer	0.00024	0.000821	CcSEcCtD
Zonisamide—Oedema—Doxorubicin—bone cancer	0.000239	0.000817	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Methotrexate—bone cancer	0.000239	0.000815	CcSEcCtD
Zonisamide—Fatigue—Methotrexate—bone cancer	0.000238	0.000814	CcSEcCtD
Zonisamide—Infection—Doxorubicin—bone cancer	0.000238	0.000812	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000236	0.000805	CcSEcCtD
Zonisamide—Shock—Doxorubicin—bone cancer	0.000235	0.000804	CcSEcCtD
Zonisamide—Nervous system disorder—Doxorubicin—bone cancer	0.000235	0.000802	CcSEcCtD
Zonisamide—Thrombocytopenia—Doxorubicin—bone cancer	0.000234	0.0008	CcSEcCtD
Zonisamide—Insomnia—Epirubicin—bone cancer	0.000234	0.000799	CcSEcCtD
Zonisamide—Tachycardia—Doxorubicin—bone cancer	0.000234	0.000798	CcSEcCtD
Zonisamide—Skin disorder—Doxorubicin—bone cancer	0.000232	0.000794	CcSEcCtD
Zonisamide—Paraesthesia—Epirubicin—bone cancer	0.000232	0.000793	CcSEcCtD
Zonisamide—Hyperhidrosis—Doxorubicin—bone cancer	0.000231	0.00079	CcSEcCtD
Zonisamide—Dyspnoea—Epirubicin—bone cancer	0.000231	0.000788	CcSEcCtD
Zonisamide—Somnolence—Epirubicin—bone cancer	0.00023	0.000785	CcSEcCtD
Zonisamide—SCN2B—Developmental Biology—MMP9—bone cancer	0.000229	0.00247	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—MMP9—bone cancer	0.000229	0.00247	CbGpPWpGaD
Zonisamide—Anorexia—Doxorubicin—bone cancer	0.000228	0.000779	CcSEcCtD
Zonisamide—Feeling abnormal—Methotrexate—bone cancer	0.000228	0.000778	CcSEcCtD
Zonisamide—Dyspepsia—Epirubicin—bone cancer	0.000228	0.000778	CcSEcCtD
Zonisamide—CA1—Metabolism—NDUFA12—bone cancer	0.000227	0.00244	CbGpPWpGaD
Zonisamide—Gastrointestinal pain—Methotrexate—bone cancer	0.000226	0.000772	CcSEcCtD
Zonisamide—Decreased appetite—Epirubicin—bone cancer	0.000225	0.000768	CcSEcCtD
Zonisamide—Hypotension—Doxorubicin—bone cancer	0.000224	0.000764	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Epirubicin—bone cancer	0.000223	0.000763	CcSEcCtD
Zonisamide—Fatigue—Epirubicin—bone cancer	0.000223	0.000762	CcSEcCtD
Zonisamide—SCN11A—Axon guidance—MET—bone cancer	0.000223	0.0024	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—NDUFA12—bone cancer	0.000222	0.0024	CbGpPWpGaD
Zonisamide—Constipation—Epirubicin—bone cancer	0.000221	0.000755	CcSEcCtD
Zonisamide—SCN9A—L1CAM interactions—EGFR—bone cancer	0.000221	0.00238	CbGpPWpGaD
Zonisamide—SCN3B—Axon guidance—EGFR—bone cancer	0.00022	0.00238	CbGpPWpGaD
Zonisamide—Urticaria—Methotrexate—bone cancer	0.00022	0.00075	CcSEcCtD
Zonisamide—Body temperature increased—Methotrexate—bone cancer	0.000219	0.000746	CcSEcCtD
Zonisamide—Abdominal pain—Methotrexate—bone cancer	0.000219	0.000746	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000218	0.000745	CcSEcCtD
Zonisamide—Insomnia—Doxorubicin—bone cancer	0.000216	0.000739	CcSEcCtD
Zonisamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000216	0.00233	CbGpPWpGaD
Zonisamide—Paraesthesia—Doxorubicin—bone cancer	0.000215	0.000734	CcSEcCtD
Zonisamide—Dyspnoea—Doxorubicin—bone cancer	0.000213	0.000729	CcSEcCtD
Zonisamide—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000213	0.0023	CbGpPWpGaD
Zonisamide—Feeling abnormal—Epirubicin—bone cancer	0.000213	0.000728	CcSEcCtD
Zonisamide—Somnolence—Doxorubicin—bone cancer	0.000213	0.000727	CcSEcCtD
Zonisamide—Gastrointestinal pain—Epirubicin—bone cancer	0.000212	0.000722	CcSEcCtD
Zonisamide—SCN3A—L1CAM interactions—EGFR—bone cancer	0.000211	0.00228	CbGpPWpGaD
Zonisamide—Dyspepsia—Doxorubicin—bone cancer	0.000211	0.000719	CcSEcCtD
Zonisamide—SCN4B—Developmental Biology—MMP9—bone cancer	0.000209	0.00226	CbGpPWpGaD
Zonisamide—Decreased appetite—Doxorubicin—bone cancer	0.000208	0.00071	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000207	0.000706	CcSEcCtD
Zonisamide—CA3—Metabolism—ENO2—bone cancer	0.000207	0.00223	CbGpPWpGaD
Zonisamide—Fatigue—Doxorubicin—bone cancer	0.000206	0.000705	CcSEcCtD
Zonisamide—Urticaria—Epirubicin—bone cancer	0.000206	0.000702	CcSEcCtD
Zonisamide—Constipation—Doxorubicin—bone cancer	0.000205	0.000699	CcSEcCtD
Zonisamide—Body temperature increased—Epirubicin—bone cancer	0.000204	0.000698	CcSEcCtD
Zonisamide—Abdominal pain—Epirubicin—bone cancer	0.000204	0.000698	CcSEcCtD
Zonisamide—CA4—Metabolism—NT5C3A—bone cancer	0.000204	0.0022	CbGpPWpGaD
Zonisamide—Hypersensitivity—Methotrexate—bone cancer	0.000204	0.000695	CcSEcCtD
Zonisamide—SCN2A—L1CAM interactions—EGFR—bone cancer	0.000203	0.00219	CbGpPWpGaD
Zonisamide—SCN4A—L1CAM interactions—EGFR—bone cancer	0.000203	0.00219	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—GSTP1—bone cancer	0.000202	0.00218	CbGpPWpGaD
Zonisamide—CA9—Metabolism—NDUFA12—bone cancer	0.000199	0.00215	CbGpPWpGaD
Zonisamide—Asthenia—Methotrexate—bone cancer	0.000198	0.000677	CcSEcCtD
Zonisamide—Feeling abnormal—Doxorubicin—bone cancer	0.000197	0.000674	CcSEcCtD
Zonisamide—MAOA—Biological oxidations—CYP3A4—bone cancer	0.000197	0.00212	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—MMP2—bone cancer	0.000196	0.00211	CbGpPWpGaD
Zonisamide—CA2—Metabolism—NT5C3A—bone cancer	0.000196	0.00211	CbGpPWpGaD
Zonisamide—SCN1A—L1CAM interactions—EGFR—bone cancer	0.000196	0.00211	CbGpPWpGaD
Zonisamide—Gastrointestinal pain—Doxorubicin—bone cancer	0.000196	0.000668	CcSEcCtD
Zonisamide—Pruritus—Methotrexate—bone cancer	0.000196	0.000668	CcSEcCtD
Zonisamide—SCN3B—Developmental Biology—MMP9—bone cancer	0.000195	0.0021	CbGpPWpGaD
Zonisamide—CA3—Metabolism—DHFR—bone cancer	0.000192	0.00207	CbGpPWpGaD
Zonisamide—Hypersensitivity—Epirubicin—bone cancer	0.000191	0.000651	CcSEcCtD
Zonisamide—Urticaria—Doxorubicin—bone cancer	0.00019	0.000649	CcSEcCtD
Zonisamide—Body temperature increased—Doxorubicin—bone cancer	0.000189	0.000646	CcSEcCtD
Zonisamide—Abdominal pain—Doxorubicin—bone cancer	0.000189	0.000646	CcSEcCtD
Zonisamide—Diarrhoea—Methotrexate—bone cancer	0.000189	0.000646	CcSEcCtD
Zonisamide—CA1—Metabolism—NT5C3A—bone cancer	0.000188	0.00202	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—NDUFA12—bone cancer	0.000188	0.00202	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—MMP2—bone cancer	0.000186	0.002	CbGpPWpGaD
Zonisamide—Asthenia—Epirubicin—bone cancer	0.000186	0.000634	CcSEcCtD
Zonisamide—SCN2B—Developmental Biology—EGFR—bone cancer	0.000185	0.00199	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—EGFR—bone cancer	0.000185	0.00199	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—NT5C3A—bone cancer	0.000184	0.00199	CbGpPWpGaD
Zonisamide—Pruritus—Epirubicin—bone cancer	0.000183	0.000625	CcSEcCtD
Zonisamide—Dizziness—Methotrexate—bone cancer	0.000183	0.000624	CcSEcCtD
Zonisamide—CA3—Metabolism—GNA11—bone cancer	0.000179	0.00193	CbGpPWpGaD
Zonisamide—Diarrhoea—Epirubicin—bone cancer	0.000177	0.000604	CcSEcCtD
Zonisamide—Hypersensitivity—Doxorubicin—bone cancer	0.000176	0.000602	CcSEcCtD
Zonisamide—Vomiting—Methotrexate—bone cancer	0.000176	0.0006	CcSEcCtD
Zonisamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000175	0.00189	CbGpPWpGaD
Zonisamide—Rash—Methotrexate—bone cancer	0.000174	0.000595	CcSEcCtD
Zonisamide—Dermatitis—Methotrexate—bone cancer	0.000174	0.000595	CcSEcCtD
Zonisamide—CACNA1G—Axon guidance—MET—bone cancer	0.000173	0.00187	CbGpPWpGaD
Zonisamide—Headache—Methotrexate—bone cancer	0.000173	0.000591	CcSEcCtD
Zonisamide—Asthenia—Doxorubicin—bone cancer	0.000172	0.000586	CcSEcCtD
Zonisamide—Dizziness—Epirubicin—bone cancer	0.000171	0.000584	CcSEcCtD
Zonisamide—Pruritus—Doxorubicin—bone cancer	0.000169	0.000578	CcSEcCtD
Zonisamide—SCN4B—Developmental Biology—EGFR—bone cancer	0.000169	0.00182	CbGpPWpGaD
Zonisamide—MAOA—Biological oxidations—GSTP1—bone cancer	0.000168	0.00181	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—MET—bone cancer	0.000168	0.00181	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—MET—bone cancer	0.000168	0.00181	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—CDK4—bone cancer	0.000168	0.00181	CbGpPWpGaD
Zonisamide—CA9—Metabolism—NT5C3A—bone cancer	0.000165	0.00178	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—MET—bone cancer	0.000165	0.00178	CbGpPWpGaD
Zonisamide—Vomiting—Epirubicin—bone cancer	0.000164	0.000562	CcSEcCtD
Zonisamide—Nausea—Methotrexate—bone cancer	0.000164	0.000561	CcSEcCtD
Zonisamide—Diarrhoea—Doxorubicin—bone cancer	0.000164	0.000559	CcSEcCtD
Zonisamide—Rash—Epirubicin—bone cancer	0.000163	0.000557	CcSEcCtD
Zonisamide—Dermatitis—Epirubicin—bone cancer	0.000163	0.000556	CcSEcCtD
Zonisamide—CA3—Metabolism—CYP3A4—bone cancer	0.000162	0.00175	CbGpPWpGaD
Zonisamide—Headache—Epirubicin—bone cancer	0.000162	0.000553	CcSEcCtD
Zonisamide—SCN11A—Developmental Biology—MET—bone cancer	0.000159	0.00171	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—CDK4—bone cancer	0.000159	0.00171	CbGpPWpGaD
Zonisamide—Dizziness—Doxorubicin—bone cancer	0.000158	0.00054	CcSEcCtD
Zonisamide—SCN3A—Axon guidance—MET—bone cancer	0.000158	0.0017	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—EGFR—bone cancer	0.000157	0.0017	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—NT5C3A—bone cancer	0.000156	0.00168	CbGpPWpGaD
Zonisamide—Nausea—Epirubicin—bone cancer	0.000154	0.000525	CcSEcCtD
Zonisamide—Vomiting—Doxorubicin—bone cancer	0.000152	0.00052	CcSEcCtD
Zonisamide—SCN2A—Axon guidance—MET—bone cancer	0.000151	0.00163	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—MET—bone cancer	0.000151	0.00163	CbGpPWpGaD
Zonisamide—Rash—Doxorubicin—bone cancer	0.000151	0.000515	CcSEcCtD
Zonisamide—Dermatitis—Doxorubicin—bone cancer	0.000151	0.000515	CcSEcCtD
Zonisamide—Headache—Doxorubicin—bone cancer	0.00015	0.000512	CcSEcCtD
Zonisamide—CACNA1I—Axon guidance—MMP9—bone cancer	0.000147	0.00159	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—CDK4—bone cancer	0.000146	0.00158	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—MET—bone cancer	0.000146	0.00157	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—MMP2—bone cancer	0.000145	0.00156	CbGpPWpGaD
Zonisamide—Nausea—Doxorubicin—bone cancer	0.000142	0.000485	CcSEcCtD
Zonisamide—CACNA1H—Axon guidance—MMP2—bone cancer	0.00014	0.00151	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—MMP2—bone cancer	0.00014	0.00151	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—MMP9—bone cancer	0.00014	0.00151	CbGpPWpGaD
Zonisamide—CA3—Metabolism—GSTP1—bone cancer	0.000139	0.0015	CbGpPWpGaD
Zonisamide—SCN5A—L1CAM interactions—EGFR—bone cancer	0.000138	0.00148	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—MMP2—bone cancer	0.000137	0.00148	CbGpPWpGaD
Zonisamide—CA13—Metabolism—PTGS2—bone cancer	0.000137	0.00148	CbGpPWpGaD
Zonisamide—CA14—Metabolism—ENO2—bone cancer	0.000133	0.00144	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—MMP2—bone cancer	0.000133	0.00143	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—MMP2—bone cancer	0.000131	0.00142	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—ENO2—bone cancer	0.00013	0.0014	CbGpPWpGaD
Zonisamide—CA6—Metabolism—ENO2—bone cancer	0.00013	0.0014	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—RB1—bone cancer	0.000127	0.00137	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—MMP2—bone cancer	0.000126	0.00136	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—MMP2—bone cancer	0.000126	0.00136	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—MET—bone cancer	0.000124	0.00133	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—CDK4—bone cancer	0.000124	0.00133	CbGpPWpGaD
Zonisamide—CA14—Metabolism—DHFR—bone cancer	0.000124	0.00133	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—MMP2—bone cancer	0.000122	0.00131	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—ENO2—bone cancer	0.000121	0.00131	CbGpPWpGaD
Zonisamide—CA7—Metabolism—ENO2—bone cancer	0.000121	0.00131	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—DHFR—bone cancer	0.00012	0.0013	CbGpPWpGaD
Zonisamide—CA6—Metabolism—DHFR—bone cancer	0.00012	0.0013	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—MET—bone cancer	0.00012	0.00129	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—CDK4—bone cancer	0.00012	0.00129	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—EGFR—bone cancer	0.000119	0.00128	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—JUN—bone cancer	0.000119	0.00128	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NDUFA12—bone cancer	0.000118	0.00127	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—MET—bone cancer	0.000118	0.00127	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—CDK4—bone cancer	0.000118	0.00127	CbGpPWpGaD
Zonisamide—CA14—Metabolism—GNA11—bone cancer	0.000115	0.00124	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—EGFR—bone cancer	0.000113	0.00122	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—GNA11—bone cancer	0.000112	0.00121	CbGpPWpGaD
Zonisamide—CA6—Metabolism—GNA11—bone cancer	0.000112	0.00121	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—CDK4—bone cancer	0.000112	0.00121	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—MET—bone cancer	0.000112	0.00121	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—DHFR—bone cancer	0.000112	0.00121	CbGpPWpGaD
Zonisamide—CA7—Metabolism—DHFR—bone cancer	0.000112	0.00121	CbGpPWpGaD
Zonisamide—CA12—Metabolism—ENO2—bone cancer	0.000112	0.00121	CbGpPWpGaD
Zonisamide—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000111	0.00119	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—MMP9—bone cancer	0.000109	0.00117	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—MDM2—bone cancer	0.000108	0.00117	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—CDK4—bone cancer	0.000108	0.00116	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MET—bone cancer	0.000108	0.00116	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—MET—bone cancer	0.000108	0.00116	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—CDK4—bone cancer	0.000108	0.00116	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—MMP9—bone cancer	0.000105	0.00113	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—MMP9—bone cancer	0.000105	0.00113	CbGpPWpGaD
Zonisamide—CA7—Metabolism—GNA11—bone cancer	0.000105	0.00113	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—GNA11—bone cancer	0.000105	0.00113	CbGpPWpGaD
Zonisamide—CA14—Metabolism—CYP3A4—bone cancer	0.000105	0.00113	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—CDK4—bone cancer	0.000104	0.00112	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—MET—bone cancer	0.000104	0.00112	CbGpPWpGaD
Zonisamide—CA12—Metabolism—DHFR—bone cancer	0.000104	0.00112	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—MMP9—bone cancer	0.000103	0.00111	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—MMP2—bone cancer	0.000103	0.00111	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—MET—bone cancer	0.000103	0.00111	CbGpPWpGaD
Zonisamide—CA6—Metabolism—CYP3A4—bone cancer	0.000102	0.0011	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—CYP3A4—bone cancer	0.000102	0.0011	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—MMP2—bone cancer	9.99e-05	0.00108	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—MMP9—bone cancer	9.97e-05	0.00107	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—MMP9—bone cancer	9.88e-05	0.00107	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—MMP2—bone cancer	9.81e-05	0.00106	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NT5C3A—bone cancer	9.76e-05	0.00105	CbGpPWpGaD
Zonisamide—CA12—Metabolism—GNA11—bone cancer	9.73e-05	0.00105	CbGpPWpGaD
Zonisamide—AOX1—Disease—ENO2—bone cancer	9.63e-05	0.00104	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—BRAF—bone cancer	9.56e-05	0.00103	CbGpPWpGaD
Zonisamide—CA7—Metabolism—CYP3A4—bone cancer	9.52e-05	0.00103	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—CYP3A4—bone cancer	9.52e-05	0.00103	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—MMP9—bone cancer	9.49e-05	0.00102	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—MMP9—bone cancer	9.49e-05	0.00102	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—JUN—bone cancer	9.42e-05	0.00102	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—MMP2—bone cancer	9.38e-05	0.00101	CbGpPWpGaD
Zonisamide—CYP2C19—Biological oxidations—CYP3A4—bone cancer	9.3e-05	0.001	CbGpPWpGaD
Zonisamide—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	9.18e-05	0.000989	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—MMP9—bone cancer	9.15e-05	0.000987	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MMP2—bone cancer	9.01e-05	0.000972	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—MMP2—bone cancer	9.01e-05	0.000972	CbGpPWpGaD
Zonisamide—CA14—Metabolism—GSTP1—bone cancer	8.95e-05	0.000965	CbGpPWpGaD
Zonisamide—CA4—Metabolism—ENO2—bone cancer	8.95e-05	0.000965	CbGpPWpGaD
Zonisamide—AOX1—Disease—DHFR—bone cancer	8.93e-05	0.000963	CbGpPWpGaD
Zonisamide—CA12—Metabolism—CYP3A4—bone cancer	8.82e-05	0.000951	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—EGFR—bone cancer	8.78e-05	0.000946	CbGpPWpGaD
Zonisamide—CA6—Metabolism—GSTP1—bone cancer	8.72e-05	0.00094	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—GSTP1—bone cancer	8.72e-05	0.00094	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—MMP2—bone cancer	8.69e-05	0.000937	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ENO2—bone cancer	8.58e-05	0.000925	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—MMP2—bone cancer	8.56e-05	0.000923	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—EGFR—bone cancer	8.5e-05	0.000916	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—EGFR—bone cancer	8.5e-05	0.000916	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—JUN—bone cancer	8.49e-05	0.000915	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—EGFR—bone cancer	8.35e-05	0.0009	CbGpPWpGaD
Zonisamide—CA4—Metabolism—DHFR—bone cancer	8.3e-05	0.000895	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ENO2—bone cancer	8.22e-05	0.000887	CbGpPWpGaD
Zonisamide—CA7—Metabolism—GSTP1—bone cancer	8.14e-05	0.000878	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—GSTP1—bone cancer	8.14e-05	0.000878	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—ENO2—bone cancer	8.07e-05	0.00087	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—EGFR—bone cancer	8.05e-05	0.000868	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—MDM2—bone cancer	8.01e-05	0.000863	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—EGFR—bone cancer	7.98e-05	0.000861	CbGpPWpGaD
Zonisamide—CA2—Metabolism—DHFR—bone cancer	7.96e-05	0.000858	CbGpPWpGaD
Zonisamide—CYP2C19—Biological oxidations—GSTP1—bone cancer	7.96e-05	0.000858	CbGpPWpGaD
Zonisamide—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	7.85e-05	0.000846	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GNA11—bone cancer	7.76e-05	0.000836	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—MMP9—bone cancer	7.75e-05	0.000836	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—EGFR—bone cancer	7.67e-05	0.000827	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—EGFR—bone cancer	7.67e-05	0.000827	CbGpPWpGaD
Zonisamide—CA1—Metabolism—DHFR—bone cancer	7.63e-05	0.000823	CbGpPWpGaD
Zonisamide—CA12—Metabolism—GSTP1—bone cancer	7.54e-05	0.000813	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—MMP9—bone cancer	7.51e-05	0.000809	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—DHFR—bone cancer	7.48e-05	0.000807	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GNA11—bone cancer	7.44e-05	0.000802	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—EGFR—bone cancer	7.4e-05	0.000798	CbGpPWpGaD
Zonisamide—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	7.39e-05	0.000796	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—MMP9—bone cancer	7.37e-05	0.000795	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—CDK4—bone cancer	7.33e-05	0.00079	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MET—bone cancer	7.33e-05	0.00079	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—BRAF—bone cancer	7.32e-05	0.000789	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ENO2—bone cancer	7.23e-05	0.00078	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PTGS2—bone cancer	7.2e-05	0.000776	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GNA11—bone cancer	7.13e-05	0.000769	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—MMP9—bone cancer	7.05e-05	0.00076	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CYP3A4—bone cancer	7.03e-05	0.000758	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GNA11—bone cancer	6.99e-05	0.000754	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ENO2—bone cancer	6.82e-05	0.000735	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MMP9—bone cancer	6.77e-05	0.00073	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—MMP9—bone cancer	6.77e-05	0.00073	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CYP3A4—bone cancer	6.74e-05	0.000727	CbGpPWpGaD
Zonisamide—CA9—Metabolism—DHFR—bone cancer	6.71e-05	0.000723	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—MMP9—bone cancer	6.53e-05	0.000704	CbGpPWpGaD
Zonisamide—AOX1—Disease—TGFBR2—bone cancer	6.47e-05	0.000698	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CYP3A4—bone cancer	6.47e-05	0.000697	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—MMP9—bone cancer	6.44e-05	0.000694	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CYP3A4—bone cancer	6.34e-05	0.000684	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—DHFR—bone cancer	6.32e-05	0.000682	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GNA11—bone cancer	6.27e-05	0.000676	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—EGFR—bone cancer	6.26e-05	0.000675	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—TP53—bone cancer	6.22e-05	0.000671	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—MDM2—bone cancer	6.14e-05	0.000661	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MMP2—bone cancer	6.11e-05	0.000659	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—EGFR—bone cancer	6.07e-05	0.000654	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GSTP1—bone cancer	6.02e-05	0.000649	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—EGFR—bone cancer	5.96e-05	0.000642	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GNA11—bone cancer	5.91e-05	0.000637	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GSTP1—bone cancer	5.77e-05	0.000622	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—EGFR—bone cancer	5.7e-05	0.000614	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CYP3A4—bone cancer	5.68e-05	0.000613	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NDUFA12—bone cancer	5.58e-05	0.000601	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GSTP1—bone cancer	5.53e-05	0.000596	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—EGFR—bone cancer	5.47e-05	0.00059	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—EGFR—bone cancer	5.47e-05	0.00059	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GSTP1—bone cancer	5.42e-05	0.000585	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP3A4—bone cancer	5.36e-05	0.000578	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—EGFR—bone cancer	5.28e-05	0.000569	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—EGFR—bone cancer	5.2e-05	0.000561	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GSTP1—bone cancer	4.86e-05	0.000524	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.79e-05	0.000516	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	4.72e-05	0.000509	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PTGS2—bone cancer	4.64e-05	0.0005	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NT5C3A—bone cancer	4.62e-05	0.000498	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MMP9—bone cancer	4.59e-05	0.000495	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GSTP1—bone cancer	4.58e-05	0.000494	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PTGS2—bone cancer	4.52e-05	0.000487	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PTGS2—bone cancer	4.52e-05	0.000487	CbGpPWpGaD
Zonisamide—AOX1—Disease—KIT—bone cancer	4.42e-05	0.000476	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ENO2—bone cancer	4.28e-05	0.000461	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PTGS2—bone cancer	4.22e-05	0.000455	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PTGS2—bone cancer	4.22e-05	0.000455	CbGpPWpGaD
Zonisamide—AOX1—Disease—BRAF—bone cancer	4.15e-05	0.000448	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—DHFR—bone cancer	3.97e-05	0.000428	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PTGS2—bone cancer	3.91e-05	0.000421	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—EGFR—bone cancer	3.71e-05	0.0004	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GNA11—bone cancer	3.71e-05	0.0004	CbGpPWpGaD
Zonisamide—AOX1—Disease—MDM2—bone cancer	3.48e-05	0.000375	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP3A4—bone cancer	3.36e-05	0.000362	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTGS2—bone cancer	3.35e-05	0.000362	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NDUFA12—bone cancer	3.35e-05	0.000362	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTGS2—bone cancer	3.12e-05	0.000336	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTGS2—bone cancer	2.99e-05	0.000322	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTP1—bone cancer	2.87e-05	0.00031	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTGS2—bone cancer	2.86e-05	0.000309	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTGS2—bone cancer	2.81e-05	0.000303	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NT5C3A—bone cancer	2.78e-05	0.0003	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTGS2—bone cancer	2.52e-05	0.000272	CbGpPWpGaD
Zonisamide—AOX1—Disease—EGFR—bone cancer	2.38e-05	0.000256	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTGS2—bone cancer	2.37e-05	0.000256	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ENO2—bone cancer	2.02e-05	0.000218	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—DHFR—bone cancer	1.88e-05	0.000202	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GNA11—bone cancer	1.76e-05	0.000189	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP3A4—bone cancer	1.59e-05	0.000172	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.58e-05	0.000171	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTGS2—bone cancer	1.49e-05	0.000161	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTP1—bone cancer	1.36e-05	0.000147	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ENO2—bone cancer	1.22e-05	0.000131	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—DHFR—bone cancer	1.13e-05	0.000122	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GNA11—bone cancer	1.06e-05	0.000114	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTP1—bone cancer	8.18e-06	8.82e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTGS2—bone cancer	7.05e-06	7.6e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGS2—bone cancer	4.24e-06	4.57e-05	CbGpPWpGaD
